A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR)

Clinical trial NCT07557446 · RECRUITING

Trial details

NCT number: NCT07557446
Sponsor: Angitia Biopharmaceuticals Guangzhou Limited
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Osteogenesis Imperfecta (OI)

Start date: 2026-06-01
Primary completion: 2028-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.